Cell of origin for brain tumours may predict response to therapy

For patients with glioma, the most common primary brain tumour, new findings may explain why current therapies fail to eradicate the cancer. A UCSF-led team of scientists has identified for the first time that progenitor rather than neural stem cells underly a type of glioma called oligodendroglioma. This distinction explains why oligodendroglioma is more responsive to therapy than other brain tumours such as glioblastoma multiforme...

Read the whole article on

More from